Actively Recruiting
Concordance and Acceptability of Self-screening Compared to Screening Carried Out by a Health Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV. A Randomized Controlled Crossover Study
Led by Centre Hospitalier Universitaire de la Réunion · Updated on 2026-02-27
300
Participants Needed
2
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate community health actions focused on women aged 30 to 65 who are living in vulnerable situations in the outer areas of Reunion Island. The study is designed to assess the effectiveness of these actions in promoting cervical cancer screening by comparing self-screening methods to those performed by health professionals. The trial focuses on human papillomavirus (HPV), a risk factor for anal cancer, in people living with HIV. Participants will engage in small group workshops to raise awareness about cervical cancer screening through discussion groups. Additionally, women who are not up to date with their cervical cancer screening will be offered an HPV self-test using a vaginal swab during an individual consultation. This randomized controlled crossover study compares the acceptability and concordance of self-screening versus professional screening. During the study, researchers will monitor how many women complete cervical cancer screening within three months after the community health intervention. Participants will attend awareness sessions and may perform self-testing. The study will track screening completion rates to measure the impact of the interventions. The trial is expected to run until March 2028, with participants followed for at least three months after intervention.
CONDITIONS
Brief Title
Concordance and Acceptability of Self-screening Compared to Screening Carried Out by a Health Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV. A Randomized Controlled Crossover Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 30 to 65
- In a vulnerable situation (beneficiary of a state or departmental social service, or referred by a charity)
- Resident in one of the two municipalities targeted by the study
- Supported by the social services of one of the two municipalities targeted by the study
- Having agreed to participate in sexual health awareness meetings organized on site
You will not qualify if you...
- Refusing to participate in the study
- Having had a hysterectomy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single session
Participants attend small group workshops on uterine cancer screening awareness and receive a proposal for an HPV self-test as part of an individual consultation if their cervical cancer screening is not up to date.
1 visit (in-person)
Duration - 3 months
Participants are observed to assess completion of cervical cancer screening after the community health intervention.
1 follow-up visit
Trial Site Locations
Total: 2 locations
1
Cegidd Saint Paul
Saint-Paul, France
Actively Recruiting
2
CegiDD Saint Pierre
Saint-Pierre, France
Actively Recruiting
Research Team
E
Emmanuelle THORE, dr
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here